Heparin and non‐heparin‐like dextrans differentially modulate endothelial cell proliferation: In vitro evaluation with soluble and crosslinked polysaccharide matrices
- 14 January 2002
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 60 (1) , 94-100
Abstract
Proliferation of endothelial cells (ECs) is a cellular step of particular importance for implanted cardiovascular biomaterials. Heparin and some synthetic water‐soluble non‐anticoagulant polysaccharides derived from dextran and bearing anionic carboxymethyl and hydrophobic benzylamine groups were first investigated for their effects on EC proliferation in vitro. The results assessed by cell counting, 3H‐thymidine uptake, and flow cytometry analysis, showed that the derivatized dextran‐bearing hydrophobic groups stimulated the EC growth in the presence of serum, whereas native dextran or dextran‐bearing anionic carboxymethyl groups were inactive and heparin was slightly inhibitory. Then, we showed that the derivatized dextran enhanced EC proliferation by potentiation of the mitogenic activities of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF‐2), two potent EC growth factors. In the presence of 2 nM of derivatized dextran, a 3‐fold and 13‐fold increase of 3H‐thymidine uptake was obtained with VEGF and FGF‐2, respectively. Finally, proliferation of ECs was investigated on crosslinked gels made of polysaccharides. It is of interest that EC proliferation was higher on gels containing the derivatized dextran than on plain hydrogels, and heparinized gels inhibited cell proliferation. From the obtained results, we propose that the synthetic non‐heparin‐like dextran may be of interest as a coating for the endothelialization of cardiovascular biomaterials. © 2002 Wiley Periodicals, Inc. J Biomed Mater Res 60: 94–100, 2002Keywords
Funding Information
- Ministère de l'Education National de la Recherche et de la Technologie (98C253, 98C254 (D.L. and J.B.M.))
- GIP-Therapeutiques Substitutives doctoral fellowships (D.M. and E.M.B.)
- Société des Amis des Sciences postdoctoral fellowship (G.D.)
This publication has 38 references indexed in Scilit:
- Vascular Smooth Muscle Cell Proliferation is Effectively Suppressed by the Non-specific Growth Factor Inhibitor SuraminJapanese Heart Journal, 2001
- Vascular cell responses to polysaccharide materials:Biomaterials, 2000
- Phosphated crosslinked guar for colon-specific drug deliveryJournal of Controlled Release, 2000
- Inhibition of Human Breast Epithelial HBL100 Cell Proliferation by a Dextran Derivative (CMDB7) with the FGF2 Autocrine LoopBiochemical and Biophysical Research Communications, 1997
- Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and a heparin-like dextran derivativeBiomaterials, 1997
- Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibitionSurgery, 1996
- Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor‐receptor binding and mitogenic activityJournal of Cellular Physiology, 1995
- Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGFJournal of Cellular Physiology, 1992
- AdoP assay detection of mycoplasmal contamination in biological mediaResearch in Virology, 1989
- Heparin protects basic and acidic FGF from inactivationJournal of Cellular Physiology, 1986